Patient Data Exhibits Review history, nurses notes, and prescriptions. Choose the most likely options for the information missing from the statement by selecting from the lists of options provided. Albuterol is a dropdown that decreases dropdown.

Rationale for correct choices: Beta adrenergic agonist: Albuterol is a short-acting beta-2 adrenergic agonist that stimulates receptors in the bronchial smooth muscle. This action leads to muscle relaxation and airway dilation, making it highly effective in relieving acute asthma symptoms such as wheezing and shortness of breath. Bronchospasm: The main therapeutic effect of albuterol is decreasing bronchospasm. By relaxing airway smooth muscle and opening narrowed bronchi, it improves airflow, oxygenation, and symptom relief during an asthma attack. Rationale for incorrect choices: Cholinergic antagonist: This drug class, including medications like ipratropium, blocks muscarinic receptors to reduce bronchoconstriction. While used in respiratory conditions, it is not the mechanism of albuterol, which works through beta-2 receptor stimulation. Beta adrenergic blocker: These medications block beta receptors and can worsen bronchospasm, particularly in asthma. Nonselective beta-blockers are contraindicated for asthmatic patients because they may trigger severe bronchoconstriction. Inflammation: Although inflammation is central to asthma pathology, albuterol does not reduce it. Corticosteroids are the drugs of choice for anti-inflammatory action, whereas albuterol only provides rapid bronchodilation. Blood pressure: Albuterol may cause mild cardiovascular side effects such as tachycardia, but it is not prescribed to lower blood pressure. Its therapeutic focus is the respiratory system, specifically bronchodilation.